Pharmaceuticals
-
Business
Pfizer shares fall as 2024 revenue and profit forecast disappoints
[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it…
Read More » -
Health News
Vertex shares pop after nonopioid painkiller posts positive midstage trial results
[ad_1] A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian…
Read More » -
Health News
Second-line diabetes meds abandoned by 40% patients
[ad_1] Two-thirds of patients discontinued their medication, switched to a different medication class or intensified their treatment Discontinuation was higher (50%)…
Read More » -
Business
Patients regain weight after stopping Eli Lilly’s Zepbound, study says
[ad_1] Eli Lilly’s drug tirzepatide was approved for weight loss by the FDA. Courtesy of Eli Lilly Patients who took…
Read More » -
Health News
Cigna shares jump on reports of abandoned Humana buyout, plans for $10 billion stock buyback
[ad_1] Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has…
Read More » -
Health News
Diabetic kidney insights: Anti-obesity drugs offer clues
[ad_1] Newswise — Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was…
Read More » -
Health News
MD Anderson and Rigel Pharmaceuticals announce strategic alliance to advance olutasidenib in AML and other cancers
[ad_1] Newswise — HOUSTON and SOUTH SAN FRANCISCO, Calif. ― The University of Texas MD Anderson Cancer Center and Rigel…
Read More » -
Health News
Diabetic kidney insights: Anti-obesity drugs offer clues
[ad_1] Newswise — Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was…
Read More »